Lipid-lowering injections mainly include PSK9 inhibitors, such as iloyumab and aliskirenumab. Lipid-lowering injections are mainly PSK9 inhibitors, able to reduce blood lipids, especially low-density lipoprotein; in addition, some promote metabolism, blood-activating drugs also have a certain role in improving lipid metabolism, but not as a lipid-lowering drugs alone, can only play an auxiliary role in oral lipid-lowering drugs, such as composite coenzymes, danhong and so on. PSK9 inhibitor scientific name for pre-protein converting enzyme Bacillus subtilis protease, can effectively enhance the liver on the metabolism of low-density lipoprotein, so as to achieve the purpose of lowering blood lipids, generally used every two weeks or once a month, more convenient than the oral drugs. Lipid-lowering injections need to be used under the guidance of cardiologists, if there is dyslipidemia, go to the hospital in time to receive regular lipid-lowering treatment.